Jorgensen Nathan D.
Insider CIK 1842523 · VYGR Chief Financial Officer · VOR Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 4,668 | $3.77 | $17.6K | 151,416 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-02-06 | 2026-02-10 | 150,500 | — | $0 | 150,500 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2026-02-06 | 2026-02-10 | 32,250 | — | $0 | 156,084 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2025-10-03 | 2025-10-07 | 7,666 | $4.78 | $36.6K | 123,834 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-24 | 103,000 | — | $0 | 103,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2025-02-21 | 2025-02-24 | 51,500 | — | $0 | 131,500 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2024-10-01 | 2024-10-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-07-08 | 2024-07-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2024-05-06 | 2024-05-07 | 834 | $1.75 | $1.5K | 189,403 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2024-05-01 | 2024-05-03 | 917 | $1.77 | $1.6K | 190,237 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 6,310 | $2.27 | $14.3K | 191,154 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2024-02-06 | 2024-02-08 | 985 | $2.32 | $2.3K | 197,464 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-01-29 | 2024-01-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award | 2024-01-29 | 2024-01-31 | 50,000 | — | $0 | 198,449 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2023-11-06 | 2023-11-08 | 834 | $1.82 | $1.5K | 145,647 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2023-09-01 | 2023-09-06 | 6,310 | $2.67 | $16.8K | 146,481 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2023-08-07 | 2023-08-09 | 834 | $2.67 | $2.2K | 152,791 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2023-05-08 | 2023-05-10 | 834 | $4.14 | $3.5K | 153,625 | SEC↗ |
| VOR Vor Biopharma Inc. | F Tax w/h | 2023-03-01 | 2023-03-02 | 6,310 | $5.51 | $34.8K | 154,459 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2023-02-06 | 2023-02-08 | 91,000 | — | $0 | 91,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award | 2023-02-06 | 2023-02-08 | 45,500 | — | $0 | 160,769 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2022-09-01 | 2022-09-06 | 86,000 | — | $0 | 86,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award | 2022-09-01 | 2022-09-06 | 86,000 | — | $0 | 115,269 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 48,076 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 3,534 | — | $0 | 29,269 | SEC↗ |